Antroquinonol® (IND) is expected to enter into phaseⅡclinical trial
Antroquinonol® (IND) Phase Ⅱ clinical trial in USA is expected to be started and approved by USFDA in 2013.
AntroQ Biotechnology Sdn Bhd(105091-W) Unit 13A, Level 2, IOI Boulevard, Jalan Kenari 4, Bandar Puchong Jaya, 47100, Selangor Darul Ehsan, Malaysia.
Golden Biotechnology Corporation, a company developing a new drug for cancer, announced that it has been granted the Orphan Drug Designation by the U.S. Food & Drug Administration (FDA) Office of Orphan Products Development for Antroquinonol, the company's lead drug candidate
Golden Biotech has established a fermentation databank. We have signed an exclusive deal with major academic institutions in Taiwan to obtain fungus strains. Currently, 4000 fungus strains have been screened and stored in our databank. Screening is done in parallel with testing and data collection of all the fungus strains.....